{"image_url":null,"html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Funeyama.hatenadiary.jp%2Fentry%2F20120511%2Fp7\" title=\"FDA\u306f\u591a\u767a\u6027\u786c\u5316\u75c7\u306e\u6839\u62e0\u306e\u306a\u3044\u6cbb\u7642\u6cd5\u306e\u5371\u967a\u6027\u306b\u3064\u3044\u3066\u8b66\u544a - \u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","categories":["FDA"],"type":"rich","author_url":"https://blog.hatena.ne.jp/uneyama/","blog_url":"https://uneyama.hatenadiary.jp/","url":"https://uneyama.hatenadiary.jp/entry/20120511/p7","version":"1.0","author_name":"uneyama","published":"2012-05-11 00:00:06","width":"100%","blog_title":"\u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b","height":"190","description":"FDA issues alert on potential dangers of unproven treatment for multiple sclerosis May 10, 2012 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm303538.htm FDA\u306f\u533b\u5e2b\u3084\u60a3\u8005\u306b\u3057\u3070\u3057\u3070\u201cliberation therapy\u201d \u307e\u305f\u306f\u201cliberation procedure\u201d\u3068\u547c\u3070\u308c\u308b\u6162\u6027\u8133\u810a\u9ac4\u9759\u8108\u6a5f\u80fd\u4e0d\u5168\uff08CCSVI\uff09\u6cbb\u7642\u306b\u95a2\u9023\u3059\u308b\u6b7b\u4ea1\u3084\u50b7\u5bb3\u306b\u3064\u3044\u3066\u8b66\u544a\u3059\u308b\u3002 \u4e00\u90e8\u306e\u7814\u7a76\u8005\u304c\u9838\u90e8\u3084\u80f8\u90e8\u306e\u9759\u8108\u304c\u72ed\u7a84\u3059\u308bCCSVI\u304c\u591a\u2026","title":"FDA\u306f\u591a\u767a\u6027\u786c\u5316\u75c7\u306e\u6839\u62e0\u306e\u306a\u3044\u6cbb\u7642\u6cd5\u306e\u5371\u967a\u6027\u306b\u3064\u3044\u3066\u8b66\u544a","provider_name":"Hatena Blog","provider_url":"https://hatena.blog"}